19 May 2013
Keywords: emisphere/lilly, trial, oral, hgh, product, emisphere, technologies
Article | 12 August 2002
Emisphere Technologies of the USA has started a Phase I clinical trialto evaluate an oral formulation of recombinant human growth ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 August 2002
17 May 2013
© 2013 thepharmaletter.com